Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention. - Wikidata - wikimedia - TriplyDB

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

http://www.wikidata.org/entity/Q37268748

about

Variations in Intraplatelet Phospho-VASP Expression Due to Pre-analytical Sample Preparations, Illustration of a Quality Control Issue in Platelet Pharmacology.In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris.

P2860

Q41620783-9C93F370-94C9-4F41-B4D4-BC689386C129 Q49386697-81944ED4-5762-409A-96E9-21E723EB19EF

P2860

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

http://www.wikidata.org/entity/Q37268748

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@en

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@nl

type

label

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@en

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@nl

prefLabel

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@en

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@nl

P1433

Q37268748-3247D28E-CAA4-4DEC-8BBB-253AD181D74A

P1476

Q37268748-8D925394-FF53-4AC8-AD01-5135F5388FEE

P2093

Q37268748-16EC4C4C-173B-4F82-95D6-F19BD7F64C6A

Q37268748-27D9249B-81E6-4BD0-9DE6-D395B077179F

Q37268748-49EA2387-7D12-4920-A419-83BB80F1F84B

Q37268748-587EC869-4E18-4DA5-A4AA-BB6B0750F70A

Q37268748-F45CE851-1CA9-4340-96DB-2C1F40376C1D

P2860

Q37268748-1151A7F9-57BC-46B2-8594-E14F51D318D7

Q37268748-1DBB27B8-6670-4D63-BAAA-685EFA397A60

Q37268748-2A842EDA-316B-4EE8-8D81-EE5DA5393242

Q37268748-3228A183-E0D9-44DD-B143-F2E442BDD397

Q37268748-465533D3-9584-416B-BD3F-EC4EE7F6820B

Q37268748-54ED1855-8EE9-4F4F-B9C5-3CFAC0587186

Q37268748-61A42F26-4ABF-451A-94B3-F799752B0A2C

Q37268748-62741300-A19B-4E08-86F7-1B407897A3CC

Q37268748-649E232B-9E21-445E-A059-187B2FC3174F

Q37268748-6D6B356C-363F-4787-BE62-74D2FE93D1DB

P304

Q37268748-B3AC227B-60D9-4992-AA6C-207E07122511

P31

Q37268748-32F408DE-B190-453F-B65D-DF8AD94F0148

P433

Q37268748-552F8F81-18FA-4CA4-9114-6AB5C86F6591

P478

Q37268748-B5784C3C-9EF9-4068-B9E4-F107825A058E

P577

Q37268748-8388A6B3-B23D-407E-8D27-03FFF199DBE0

P698

Q37268748-03F35BDC-4D6C-4EC4-88B9-828BBB404918

P921

Q37268748-2BD2FAB6-3D95-460B-85A1-C9A9026FB1C2

P932

Q37268748-4B7A825F-68B0-40CD-995B-27F2018B8625

P1433

Iranian Journal of Pharmaceutical Research

P1476

Resistance to Clopidogrel among Iranian Patients Undergoing Angioplasty Intervention.

@en

P2093

Farzad Kobarfard

http://www.w3.org/2001/XMLSchema#string

Kourosh Sheibani

http://www.w3.org/2001/XMLSchema#string

Mohammad Haji Aghajani

http://www.w3.org/2001/XMLSchema#string

Mohammad Sistanizad

http://www.w3.org/2001/XMLSchema#string

Olia Safi

http://www.w3.org/2001/XMLSchema#string

P2860

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Inter-individual variability in response to clopidogrel in patients with coronary artery disease

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

Resistance to clopidogrel: a review of the evidence.

Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches.

P304

169-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

Suppl

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24250685

http://www.w3.org/2001/XMLSchema#string

P921

P932

3813374

http://www.w3.org/2001/XMLSchema#string